A pharmacy merchant account is a payment processing arrangement for online, mail order or compounding pharmacies. Underwriting is the strictest in healthcare because card brands maintain specific rules for pharmacy merchants on top of standard acquirer requirements, driven by the scale of counterfeit and unlicensed operations in the category.
01
Why pharmacy underwriting is stricter than everything else
Card brands maintain pharmacy-specific requirements that sit above the acquirer's own risk assessment, which is unusual. Most categories are underwritten by the acquirer alone.
The reason is scale. Counterfeit and unlicensed pharmacy operations represent one of the largest categories of card network fraud globally, and the networks responded with registration requirements and ongoing monitoring rather than leaving it to individual acquirers.
For a legitimate accredited pharmacy this is genuinely good news. The barrier that makes approval slow also keeps your competitive set small and makes your accreditation commercially valuable rather than merely administrative.
02
Accreditation is the entry ticket
NABP accreditation, including VIPPS for internet pharmacies, is the credential that moves you from an automatic decline to a genuine application.
Alongside it, underwriting will want state licensure in every state you dispense to, a named pharmacist-in-charge, DEA registration where controlled substances are involved, and clear documentation of your sourcing chain.
The sourcing chain matters more than operators expect. An acquirer's exposure in this category is a counterfeit product reaching a patient, so being able to demonstrate where product comes from is central to the file rather than peripheral to it.
| Requirement | Why it matters to the acquirer |
|---|---|
| NABP / VIPPS accreditation | Independent verification the operation is legitimate |
| State licensure per state served | Establishes you are dispensing lawfully everywhere you ship |
| Named pharmacist-in-charge | Accountable individual with a verifiable licence |
| DEA registration | Required where controlled substances are dispensed |
| Sourcing documentation | Counterfeit product reaching a patient is the core exposure |
| 503A / 503B registration | Determines what you may lawfully compound and at what scale |
03
Controlled substances raise the bar again
Where a pharmacy dispenses scheduled medications, both the underwriting and the ongoing monitoring intensify.
Expect scrutiny of prescription verification processes, whether prescribing relationships satisfy telehealth requirements for controlled substances, and how you handle the states with tighter rules than federal scheduling requires.
This area has moved repeatedly since the public health emergency flexibilities, and an acquirer will want to see that your compliance posture reflects the current rules rather than the ones in force when you launched.
04
Compounding pharmacies have a specific approval path
The 503A and 503B distinction is not just a regulatory matter, it changes how you are underwritten.
A 503A pharmacy compounding for individually identified patients presents a different risk profile to a 503B outsourcing facility producing batches under CGMP. The volume, the customer type, whether you sell B2B to telehealth platforms or direct to patients, and whether you compound anything in a category under active regulatory attention all shape the outcome.
Compounded GLP-1 products are the live example. That category has drawn sustained attention, and pharmacies compounding in it should expect questions about shortage list status and their own regulatory position rather than assuming volume alone makes the case.
Accreditation is the entry ticket
Tell us your accreditation status and dispensing model and we will make the introduction.
Step 1 of 5
What is your website?
Your domain is enough.
- Rated on Trustpilot
- Part of DTC SEO Agency
- Award-winning SEO agency
- $150M revenue generated for clients
- We built and run our own telehealth brand